Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2014; 20(18): 5252-5262
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5252
Table 1 Treatment regimens for Helicobacter pylori eradication
TreatmentRegimensDuration
Standard triple therapyPPI (standard dose), amoxicillin (1 g), and clarithromycin (500 mg) twice daily7-14 d
PPI (standard dose), metronidazole (500 mg), and clarithromycin (500 mg) twice daily
Bismuth containing quadruple therapyPPI (standard dose) twice daily, bismuth (standard dose), metronidazole (500 mg), and tetracycline (500 mg) four times daily10-14 d
Sequential therapyPPI (standard dose) and amoxicillin (1 g) twice daily for 5 d, followed by PPI (standard dose), metronidazole (500 mg), and clarithromycin (500 mg) twice daily for 5 d10 d
Concomitant therapy (Non-bismuth quadruple therapy)PPI (standard dose), amoxicillin (1 g), metronidazole (500 mg), and clarithromycin (500 mg) twice daily10 d
Hybrid therapyPPI (standard dose), amoxicillin (1 g) twice daily for 7 d, followed by PPI (standard dose), amoxicillin (1 g), metronidazole (500 mg), and clarithromycin (500 mg) twice daily for 7 d14 d
Levofloxacin-based triple therapyPPI (standard dose), amoxicillin (1 g), and levofloxacin (500 mg) twice daily10 d
LOAD regimenLevofloxacin (250 mg) with breakfast, omeprazole (40 mg) before breakfast, nitazoxanide (500 mg) twice daily with meals, and doxycycline (100 mg) at dinner7 d or 10 d
Rifabutin-based triple therapyPPI (standard dose), amoxicillin (1 g), and rifabutin (150 mg) twice daily7-14 d
Furazolidone-based quadruple therapyLansoprazole (30 mg), tripotassiumdicitratobismuthate (240 mg), tetracycline (1 g), and furazolidone (200 mg) twice daily7 d
Novel quadruple therapyPARC; rabeprazole (20 mg, thrice daily for 10 d), amoxicillin (1000 mg, thrice daily for 10 d), rifabutin (150 mg, starting from day 6, twice daily for 5 d), and ciprofloxacin (500 mg, starting from day 6, twice daily for 5 d)10 d
PBRC (allergic to amoxicillin); rabeprazole (20 mg, thrice daily for 10 d), bismuth subcitrate (240 mg, 4 times daily for 10 d), rifabutin (150 mg, twice daily for 10 d), and ciprofloxacin (500 mg, twice daily for 10 d)
High dose dual therapyLansoprazole (30 mg) and amoxicillin (750 mg) thrice daily14 d
Table 2 Current recommended first line regimens of Helicobacter pylori eradication
Guidelines RegimensDuration
Maastricht IV/Florence (2012)[6]Clarithromycin containing treatments in areas of low clarithromycin resistance (Bismuth-containing quadruple treatment is an alternative)7-14 d
Bismuth-containing quadruple treatment in areas of high clarithromycin resistance (if not available, sequential treatment or non-bismuth quadruple treatment is recommended)-
-
Asian Pacific (2009)[15]Standard PPI-based triple therapy7 d
(Bismuth-containing quadruple treatment is an alternative)-
American College (2007)[14]Standard PPI-based triple therapy OR14 d
Bismuth-containing quadruple treatment10-14 d
(Sequential therapy may be an alternative)-
South Korea (2013)[82]Standard PPI-based triple therapy7-14 d
(Bismuth-containing quadruple treatment is an alternative)7-14 d
Japan (2009)[16]Standard PPI-based triple therapy7 d
Canada (2005)[112]Standard PPI-based triple therapy14 d
ESPGHAN and NASPGHAN for children (2011)[113]Standard PPI-based triple therapy-
Bismuth-containing quadruple treatment10-14 d
Sequential therapy10 d